GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Cash Flow from Discontinued Operations

CTOR (Citius Oncology) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Citius Oncology's cash flow from discontinued operations for the six months ended in Sep. 2024 was $0.00 Mil. It means Citius Oncology received $0.00 Mil from the sale of part of business quarterly. Citius Oncology's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Citius Oncology Cash Flow from Discontinued Operations Historical Data

The historical data trend for Citius Oncology's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology Cash Flow from Discontinued Operations Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24
Cash Flow from Discontinued Operations
- - -

Citius Oncology Semi-Annual Data
Sep22 Sep23 Sep24
Cash Flow from Discontinued Operations - - -

Citius Oncology Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citius Oncology Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Citius Oncology's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Citius Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
ETST ASRT MRMD RMTI SCYX CPIX INCR SXTC RSCI INIS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Website
https://www.citiusonc.com
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.